Home » Topics » BioWorld Science

BioWorld Science
RSS

Dacliximab receives patent protection in U.S.

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

MedImmune Lyme disease vaccine shows superior activity in animals

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

Lidak reports discovery of antiinflammatory peptides

July 5, 1996

Role of adhesion receptors in chronic inflammation reviewed

July 5, 1996

Prosorba trial initiated in arthritis sufferers

July 5, 1996

Mobic introduced in Argentina

July 5, 1996

Eisai claims prostaglandin/leukotriene production inhibitors for pain and inflammation

July 5, 1996

Searle claims NOS inhibitors

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.